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Introduction: Obesity is a growing problem in the 
Western world. Correlations have been found between 
increasing body mass index (BMI) and breast cancer. 
The objectives were to establish whether a relationship 
exists between BMI and breast cancer and to investigate 
any association between BMI and tumour oestrogen 
receptor expression. 
Method: Clinical and socio-demographic details 
(age, menopausal status, height and weight) of a sample 
of women with breast cancer operated in 2010 were 
collected, dividing the group into oestrogen receptor 
positive (ER+) and negative (ER–) subgroups. The 
average BMI of each subgroup was compared to the 
mean BMI of a sample of the general Maltese female 
population obtained from the European Health 
Examination Survey 2010 Report (Pilot Study) by virtue 
of an ANOVA test. Subsequently, the relations between 
oestrogen receptor expression and each of menopausal 
status, age and BMI were statistically analysed using 
chi-squared analysis and two-sample t-tests.   
 
Results: A total of 103 patients were studied. 72 
patients (age range: 40 – 90 years) had ER+ malignancy 
and 31 patients (29 – 81 years) had ER- malignancy. The 
mean  BMI’s   of   the  ER+  and  ER- subgroups were 30.1 
and 27.1 respectively, while that of the female general 
population (29 – 90 years) was 28.4. Analysis revealed a 
significant  difference  between  the  BMI’s  of  the  ER+  and  
ER- subgroups (p<0.05) but no difference between each 
receptor subgroup and the general population. Neither 
menopausal status nor age was found to correlate with 
positive oestrogen receptor expression.  
Conclusions: Women with ER+ malignancy tended 
to be significantly more obese than those with ER- 
breast cancer. However, neither subgroup had a mean 
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Introduction 
Obesity is a growing problem in Western developed 
countries. According to data from the European Health 
Interview Survey, published by Eurostat in November 
2011, Malta ranked second, after the UK, in the 
prevalence of obesity in females, with 21.1% of women 
having a BMI over 30.1 Research has long since 
demonstrated a relationship between obesity and various 
forms of malignancy, including colon cancer, 
endometrial cancer, renal cell carcinoma and 
oesophageal adenocarcinoma.2, 3 In addition to this, 
several studies have also shown a strong correlation 
between body mass and postmenopausal breast cancer.4-6 
Moreover, it has been confirmed that overweight women 
with breast cancer have a poorer prognosis than thinner 
women,7 with obese patients having a 46% increase in 
the risk of metastatic disease, roughly twice the risk of 
recurrence over a 5-year period and a 60% risk of death 
over a 10-year period.3  
Our study aimed to establish whether the 
relationship between body mass and breast cancer also 
holds true in the Maltese populace, given the high 
prevalence of overweight and obese individuals. 
Moreover, we attempted to find an association between 
obesity and the oestrogen receptor status of the breast 
neoplasia.   
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We performed a hospital-based retrospective study 
on a number of breast cancer patients seen by one of two 
surgical firms at Mater Dei Hospital Breast Clinic, 
Malta. Following acquisition of appropriate hospital 
approval, 103 histologically confirmed breast cancer 
cases were ascertained between the 1st of January 2010 
and the 31st of December 2010. Eligible cases had to be 
females with a Maltese citizenship. For each case, 
various anthropomorphological details, including age, 
height, weight and menopausal status, were obtained 
from patient hospital records, and the BMI was then 
calculated by dividing the weight (in kilograms) by the 
height squared (in squared metres).  
The sample was then divided into two groups; those 
patients with ER+ and those with ER– malignancies.  
This data was subsequently compared with the average 
BMI of a sample of the Maltese female population, 
obtained from the European Health Examination Survey 
2010 Report (Pilot Study),8 taking only those females 
aged between 29 and 90 years (the same age range as the 
breast cancer patient sample), in order to investigate 
whether significant differences exist between the BMIs 
of the general Maltese female population, the ER+ 
sample and the ER– sample.  
Using appropriate statistical tests, the relationship 
between tumour oestrogen receptor expression and each 




A summary of the BMI data in the histologically 
confirmed breast cancer cases and the general population 
is shown in Table 1. Chart 1 compares the BMI 
distributions of the ER+ and ER– groups respectively. 
By virtue of an Analysis of Variance (ANOVA) 
test, the mean BMIs of the ER+ sample, the ER– sample 
and the general population were compared in order to 
ascertain whether breast cancer patients in each 
subgroup were significantly more obese than the Maltese 
female general population. A significant difference was 
found between the three distributions (p=0.0246). Post 
hoc Tukey testing demonstrated a significant difference 
(at the 95% significance level) between the BMIs of the 
ER+ and ER– groups only, but no significant difference 
between each breast cancer subgroup individually and 
the general population. 
Table 2 divides each oestrogen receptor subgroup 
according to menopausal status. The correlation between 
oestrogen receptor status and menopausal status was 
explored using a χ2-test. The resulting p-value for this 
analysis was 0.0820, suggesting that there is no 
correlation between oestrogen receptor status and 
menopausal status at the 95% significance level.  
A correlation between oestrogen receptor status and 
age was sought using a two-sample t-test with equal 
variance and this yielded a p-value of 0.0448, signifying 
that patients with ER- breast cancer tend to be younger 
than those with ER+ cancer. Using the same test, 
correlation between BMI and oestrogen receptor status 
yielded a p-value of 0.0116. This implies that both 
relations are significant at the 95% significance level, 
the latter correlation being considerably stronger.  
Since age is a potential confounding variable in the 
relationship between the oestrogen receptor status of 
breast cancer and BMI, multivariate linear regression 
analysis was carried out in order to account for 
differences in age. The results are shown in Table 3. The 
results demonstrate a p-value of 0.011 for the oestrogen 
receptor status / BMI relationship and 0.700 for the age / 
BMI relationship, therefore reaching the conclusion that 
age does not significantly confound the relationship 
between tumour oestrogen receptor expression and BMI. 
Hence, positive oestrogen receptor status remains 
significantly associated with increasing BMI, even when 
adjusted for age. 
 
Discussion 
The study concluded a number of points in relation 
to breast cancer in the Maltese population. Firstly, 
Maltese women with breast cancer were found to be 
neither more nor less obese than the general female 
population. However, those women with ER+ 
malignancy are significantly more obese than those with 
ER- breast cancer.  
Breast cancer is by far the commonest malignancy 
in females in Malta, with the incidence rate approaching 
1 case per 1,000 people.9 Obesity has been strongly 
linked with breast cancer in numerous studies,2-6, 10 such 
that the observed rises in incidence in breast cancer 
might well be linked to the dramatic increases in the 
number of overweight and obese individuals.11 Data 
from the European Health Interview Survey 2008 
revealed that in Malta, 28.4% of females over the age of 
15 years were overweight and 20.6% were obese,12 
while the European Health Examination Survey 2010 
report revealed that in females over the age of 18 years, 
25.6% were overweight but 32.0% were obese.8 This 
demonstrates a very high and ever increasing prevalence 
of obesity in the Maltese Islands.  
However, why this study demonstrated no 
statistically significant difference between the BMIs of 
the European Health Interview Survey 2010 sample, the 
ER+ sample and the ER– sample is not clear. One 
possibility is that the sample size is too small to detect 
the difference. Another possibility is that since the 
prevalence of obesity is so high in Malta, it is difficult to 
detect a difference between the overweight / obese and 
the normal weight population since the risk factor being 
studied (i.e. obesity) is not present in only a small 
minority of the population.  
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 Sample Size Mean BMI (kg/m2) Standard Deviation 
95% Confidence 
Intervals 
ER+ 72 30.1 5.61 28.8 – 31.4 
ER– 31 27.1 4.91 25.3 – 28.9 
General Maltese Female Population 89 28.4 5.43 26.4 – 27.3 
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Table 2: Menopausal status of breast cancer cases 













Table 3: Multivariate analysis of oestrogen receptor status, BMI and age 
 
 
In addition to this, the incidence of breast cancer in 
Malta is relatively low compared to that of other 
countries like Belgium and France, where the incidence 
rates are roughly 140 cases per 100,000 people,9 and this 
may make finding a relationship between breast cancer 
and obesity all the more difficult.  
The relationship between obesity and ER+ 
malignancy holds true in Malta. This relationship has 
been demonstrated repeatedly in other studies.11, 13-15 The 
pathogenesis linking obesity and ER+ breast cancer is 
not completely clear. In post-menopausal women, 
oestrogen is largely produced by adipose tissue, which 
possesses the enzyme aromatase, which can synthesize 
oestrone.16 Obese individuals have higher levels of 
circulating oestrogens and reduced levels of the steroid 
carrier sex hormone-binding globulin.7 The high blood 
free oestrogen levels may be associated with increased, 
and possibly aberrant, division of breast epithelial cells. 
However, how, and even if, this high level of oestrogen 
results in anomalous oestrogen receptor expression on 
breast cancer cells remains unclear. It is likely that other 
adipocytokines apart from oestrogen are involved in the 
pathogenesis.7  
This study demonstrated no association between 
positive oestrogen receptor status and menopausal status 
but showed an association between increasing age and 
positive oestrogen receptor expression. Clark, McGuire 
and Osborne found a similar result in almost 3,000 
women with primary breast cancer, showing that when 
patient age and menopausal status were analysed 
together, the primary determinant of positive oestrogen 
receptor status was age.17.  Other studies, however, 
demonstrated that post-menopausal women had a greater 
tendency for developing ER+ disease. 18, 19 The positive 
correlation of oestrogen receptor status with age may 
stem, in part, from the correlation between age and an 
increasing BMI, with the European Health Interview  
Survey (2008) and the European Health 
Examination Survey (2010) demonstrating increasing 
BMI with age in the Maltese population.8, 12  
The fact that a small sample size was taken is a 
significant limitation of this study, as is the fact that the 
heights and weights of the sample of patients taken were 
obtained from the patient records rather than being 
measured directly. In addition, the impact of other 
potentially confounding variables (for example, 
BMI Coefficient Standard Error t p>|t| 
95% Confidence 
Intervals 
Oestrogen Receptor 3.081 1.192 2.590 0.011 0.717 – 5.446 
Age - 0.018 0.048 - 0.390 0.700 - 0.113 – 0.076 
Constant (alpha) 28.168 2.875 9.800 0.000 22.463 – 33.872 
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nulliparity, use of the oral contraceptive pill and 
smoking) were not investigated. Finally, the fact that 
BMI was taken as a measure of obesity may in itself be a 
limitation since BMI does not always correlate with 
body fat content.  
 
Conclusion 
Maltese women with ER+ tumours have been found 
to be significantly more obese than those with ER– 
tumours but neither group was found to be significantly 
more or less obese than the general population. Positive 
oestrogen receptor expression correlated with obesity, 
with obese women being more at risk of developing ER+ 
malignancy.  
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